Phase 2 study of DS-8201a in subjects with colorectal cancer [DESTINY-CRC01]
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/102108
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: investigational material(s)
Generic name etc : DS-8201a
INN of investigational material : trastuzumab deruxtecan
Therapeutic category code : 42- Antineoplastic agents
Dosage and Administration for Investigational material : IV solution (Once every 3 weeks, 6.4 mg/kg)
control material(s)
Generic name etc : -
INN of investigational material : -
Therapeutic category code :
Dosage and Administration for Investigational material : -
Primary outcome(s): efficacy
The objective response rate
RECIST Version 1.1
Study Design: multi center, open-label, 3-cohort study
创建时间：
2018-02-15
